Proposing the best MET inhibitor to improve anti-PD-1 efficacy in HCC

被引：0
|
作者：
de Azevedo, Ricardo A.
Turner, Broderick
Jayaprakash, Priyamvada
Bhanu, Krithikaa Rajkumar
Srinivasamani, Anupallavi
Morrow, Brittany
Winkler, Michelle
Hedge, Shweta Mahendra
Liu, Arthur
Slay, Ravaen
Curran, Michael A.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5745
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5745
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Anti-PD-1 therapy in the frontline
    David Killock
    [J]. Nature Reviews Clinical Oncology, 2016, 13 (12) : 715 - 715
  • [42] Pharmacovigilance and efficacy of a Temporary Use Autorization (TUA) cohort of anti-PD-1
    Hirsch, L.
    Hurgon, A.
    Giard, C.
    Ho, Y.
    Piperno-Neumann, S.
    Daniel, C.
    Livartowski, A.
    Beaucaire-Danel, S.
    Rodrigues, M.
    Ung, M.
    Gantzer, A.
    Munck, N.
    Glaisner, S.
    Bidard, F-C.
    Servois, V.
    Cottu, P.
    Romano, E.
    Escalup, L.
    Pierga, J-Y.
    Loirat, D.
    [J]. BULLETIN DU CANCER, 2016, 103 (06) : S111 - S111
  • [43] Replacement of anti-PD-1 drugs with prolgolimab during treatment, safety and efficacy
    Andabekov, Timur
    Napolskaia, Elena
    Rodina, Maria
    Khlobystina, Alina
    Gulo, Elizaveta
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] An Interactive Interface for Prediction of Anti-PD-1 Efficacy in Lung Cancer Patients
    Richard, C.
    Fumet, J.
    Chevrier, S.
    Derangere, V.
    Boidot, R.
    Truntzer, C.
    Ghiringhelli, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S921 - S921
  • [45] Anti-PD-1 antibodies: immune-related adverse events and efficacy
    [J]. Reactions Weekly, 2019, 1739 (1) : 6 - 6
  • [46] A human receptor occupancy assay to measure anti-PD-1 binding in patients with prior anti-PD-1
    Junker, Fabian
    Gulati, Pratiksha
    Wessels, Uwe
    Seeber, Stefan
    Stubenrauch, Kay-Gunnar
    Codarri-Deak, Laura
    Markert, Christoph
    Klein, Christian
    Camillo Teixeira, Priscila
    Kao, Henry
    [J]. CYTOMETRY PART A, 2021, 99 (08) : 832 - 843
  • [47] The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
    Matson, Vyara
    Fessler, Jessica
    Bao, Riyue
    Chongsuwat, Tara
    Zha, Yuanyuan
    Alegre, Maria-Luisa
    Luke, Jason J.
    Gajewski, Thomas F.
    [J]. SCIENCE, 2018, 359 (6371) : 104 - +
  • [48] Preclinical combination strategies to enhance the efficacy of the anti-PD-1 antibody pembrolizumab
    Pinheiro, Elaine M.
    Hinton, Marlene
    Mangadu, Ruban
    Cai, Mingmei
    Phan, Uyen
    Nebozhyn, Michael
    Hirsch, Heather
    Loboda, Andrey
    Javaid, Sarah
    Wang, Yaolin
    Sriram, Venkataraman
    Phillips, Joseph H.
    McClanahan, Tern
    Long, Brian
    [J]. CANCER RESEARCH, 2016, 76
  • [49] Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC
    Samuel, Evangeline
    Lie, Gabrielle
    Balasubramanian, Adithya
    Hiong, Alison
    So, Yeojeong
    Voskoboynik, Mark
    Moore, Maggie
    Shackleton, Mark
    Haydon, Andrew
    John, Tom
    Mitchell, Paul L. R.
    Markman, Ben
    Briggs, Peter
    Parakh, Sagun
    [J]. CLINICAL LUNG CANCER, 2021, 22 (03) : E425 - E430
  • [50] Excess weight and efficacy of anti-PD-1 antibodies in advanced cancer patients
    Rogado, J.
    Romero Laorden, N.
    Sanchez Torres, J. M.
    Ramos-Levi, A.
    Pacheco-Barcia, V. E.
    Ballesteros Garcia, A. I.
    Arranz, R.
    Lorenzo, A.
    Gullon, P.
    Garrido, A.
    Serra, J. M.
    Donnay, O.
    Adrados, M.
    Costas, P.
    Aspa, J.
    Alfranca, A.
    Mondejar, R.
    Colomer Bosch, R.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
12345